Diabetes & Obesity
Metformin improved body composition and fasting insulin in obese insulin-resistant children
Published in Obesity and Diabetes Week, July 31st, 2006
According to a study from Australia, "Metformin therapy for adults and children with type 2 diabetes is well established. However, its role in the treatment of insulin resistance and obesity in children and adolescents is less clearly defined. We assessed the effect of metformin on body composition and insulin sensitivity in pediatric subjects with exogenous obesity. Patients referred to a pediatric endocrine clinic were enrolled in a randomized, double-blind, crossover trial."
"Twenty-eight patients (13 males) aged 9-18 yr participated in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes & Obesity
Calpain-10 polymorphisms contribute to diabetes risk by regulating abdominal obesity - Diabetes & Obesity
Novel cyanopyrrolidine analogues show diabetes and obesity therapy potential - Diabetes & Obesity
PPAR alpha improves pancreatic adaptation to insulin resistance and reduces lipotoxicity - Diabetes Epidemiology
Hepatic lipase gene variant impacts coronary heart disease risk differently in obese diabetics - Diabetes Therapy
alpha-Lipoic acid regulates AMP-activated protein kinase - Allergy & Immunology
beta cell autoimmunity linked to introduction age of fruits, berries and roots - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
